47th Annual Current Concepts in Surgical Pathology

  • Continuing Education
adenoid cystic carcinoma

-

Registration Deadline: October 30

Refine your diagnostic skills in surgical pathology with this expert-led, five-day live virtual course from Harvard Medical School, featuring illustrative cases, subspecialty insights, and practical strategies for clinical excellence.

  • Live Online

This course is taught online in real time.

 

Additionally, all sessions will be recorded and made available to participants for online viewing for 60 days after the end of the course.

$1,095

This is the standard price, for a full list of profession pricing see below.
View All

Continuing Education

Earn up to:
46.00 AMA PRA Category 1 Credit(s) ™
View All

Five Days

Please view the Schedule for a full description of the program.

On This Page

Overview

Join us for a comprehensive five-day live virtual course in surgical pathology, led by expert faculty from Mass General Brigham and Harvard Medical School. This year’s course features an outstanding review of multiple core areas of surgical pathology, including practical approaches to recurrent diagnostic problems, updates in tumor classification, ancillary diagnostic and biomarker testing, integration of molecular pathology into contemporary diagnostics, and quality and safety in pathology. This course is perfect for both academic and community pathologists looking to stay at the forefront of their field, as well as pathologists and trainees seeking to broaden their knowledge base. The course emphasizes key theoretical and practical aspects of surgical pathology and is designed to provide insights and skills that can be applied directly to daily practice. 

Can’t attend the livestream? All presentations are recorded and will be available for 60 days after the course ends, so you can review them at your convenience. 

Learning Objectives

  • Appropriately apply criteria for pathologic diagnoses in multiple areas of surgical pathology.
  • Recognize unusual entities, including those newly described.
  • Evaluate the decision-making process used to arrive at specific diagnoses.
  • Utilize contemporary tumor classification systems and reporting guidelines.
  • Apply immunohistochemistry and/or molecular studies judiciously to establish or confirm diagnoses.

Developed and Offered By:

  • Massachusetts General Hospital logo

Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Massachusetts General Hospital Department of Pathology.

Who Should Participate

Pathologists

Schedule

All agenda sessions are in Eastern Time.

Day 1

Monday, October 26, 2026

Welcome and Introduction

William Faquin; Melinda Lerwill; Esther Oliva

7:45-8:00 am

Head and Neck Squamous Cell Carcinoma Precursors and Subtypes

William Faquin

8:00-9:00 am

Perplexing Papillary Proliferations of the Breast

Melinda Lerwill

9:00-10:00 am

Break

10:00-10:15 am

The Spectrum of Ovarian Epithelial Neoplasia

Kyle Devins

10:15-11:15 am

Colitis: Morphologic Patterns and Differential Diagnosis

Michael Drage

11:15 am-12:00 pm

Midday Break

12:00-12:30 pm

Slide Seminar: Breast Pathology

Dennis Sgroi

12:30-1:15 pm

Slide Seminar: Gynecologic Pathology - The Conundrum of Mesenchymal Neoplasia

Esther Oliva

1:15-2:00 pm

Break

2:00-2:15 pm

Pleural and Peritoneal Mesothelioma: Differential Diagnosis

Yin Hung

2:15-3:00 pm

A Systematic Approach to Lymph Node Diagnosis

Judith Ferry

3:00-4:00 pm

Question Period

Esther Oliva

4:00-4:10 pm

Break

4:10-4:20 pm

Gestational Trophoblastic Disease

Lawrence Lin

4:20-5:20 pm

Placental Infection: Beyond Acute Chorioamnionitis

Katelyn Dannheim

5:20-6:05 pm

Question Period

Esther Oliva

6:05-6:15 pm

Day 2

Tuesday, October 27, 2026

Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia

Robert Hasserjian

8:00-9:00 am

Endometrial Biopsy Interpretation

Kyle Devins

9:00-10:00 am

Break

10:00-10:15 am

Molecular Immunohistochemistry for the Diagnosis of Soft Tissue Tumors

Jason Hornick

10:15-11:15 am

Cytology / Small Biopsy Diagnosis of Non-Ductal Neoplasms of the Pancreas

Lisa Zhang

11:15 am-12:00 pm

Midday Break

12:00-12:30 pm

Slide Seminar: Hematopathology

Judith Ferry

12:30-1:15 pm

Slide Seminar: Gastrointestinal & Pancreatobiliary Pathology

Stuti Shroff

1:15-2:00 pm

Break

2:00-2:15 pm

Hematopathology's Greatest Pitfalls and How to Avoid Them

Aliyah Sohani

2:15-3:00 pm

Update on Ancillary Studies for the Diagnosis of Non-Melanocytic Cutaneous Tumors

Mai Hoang

3:00-3:30 pm

Assessment and Reporting for Neoadjuvant Cutaneous Excisions

Ruth Foreman

3:30-4:00 pm

Question Period

Melinda Lerwill

4:00-4:10 pm

Break

4:10-4:20 pm

Molecular Pathology and Precision Oncology Care

Charlotte Wang

4:20-5:20 pm

Lymphomas of the Central Nervous System: A Practical Approach

David Meredith

5:20-6:05 pm

Question Period

Melinda Lerwill

6:05-6:15 pm

Day 3

Wednesday, October 28, 2026

The Good, the Bad, and the Ugly: Intraductal Proliferations of the Breast

Melinda Lerwill

8:00-9:00 am

Update in Esophageal Pathology: Esophagitis and Barrett's Esophagus

Jonathan N. Glickman

9:00-10:00 am

Break

10:00-10:15 am

Contemporary Issues in the Classification of Lobular Carcinoma

S. Emily Bachert

10:15-10:45 am

Update on Breast Biomarkers

Amy Ly

10:45-11:15 am

Diagnosing Oncocytic Renal Neoplasms in the Molecular Era

Zhichun Lu

11:15 am-12:00 pm

Midday Break

12:00-12:30 pm

Slide Seminar: Bone and Soft Tissue Pathology

Ivan Chebib

12:30-1:15 pm

Slide Seminar: Pulmonary Pathology

Yin Hung

1:15-2:00 pm

Break

2:00-2:15 pm

Location is Key - Pathology of the Sellar Region

Maria Martinez-Lage Alvarez

2:15-3:00 pm

Diagnostic Issues in Primary Hepatocellular Neoplasms

Angela Shih

3:00-3:30 pm

The Many Faces of Colorectal Polyps

Lisa Zhang

3:30-4:00 pm

Question Period

William Faquin

4:00-4:10 pm

Break

4:10-4:20 pm

Pheochromocytoma and Paraganglioma

Justine A. Barletta

4:20-4:50 pm

Histologic Features of Pulmonary Infections

Angela Shih

4:50-5:20 pm

A Framework for the Diagnostic Approach to Sinonasal Tumors

Adam Fisch

5:20-6:05 pm

Question Period

William Faquin

6:05-6:15 pm

Day 4

Thursday, October 29, 2026

Biological Predictability and Gray Zones of Diagnosis in Thyroid Neoplasia Even in the Age of Molecular Diagnosis

Peter Sadow

8:00-9:00 am

Practical Approach to Histotyping and Ancillary Testing of Endometrial Carcinoma

Gulisa Turashvili

9:00-10:00 am

Break

10:00-10:15 am

The Sprectrum of Inflammatory Breast Lesions

Gulisa Turashvili

10:15-10:45 am

Testicular Sex Cord-Stromal Tumors: High-Risk Features and Emerging Entities

Miranda Machacek

10:45-11:15 am

Update on the WHO Classification of Lung Tumors

Mari Mino-Kenudson

11:15 am-12:00 pm

Midday Break

12:00-12:30 pm

Slide Seminar: Genitourinary Pathology

Chin-Lee Wu

12:30-1:15 pm

Slide Seminar: Dermatopathology

Jakob Moran

1:15-2:00 pm

Break

2:00-2:15 pm

Spindle Cell Lesions of the Breast: Avoiding Perilous Pitfalls

Susan Lester

2:15-3:00 pm

Duodenal Biopsy Pathology: Celiac Disease and Its Mimickers

Jonathan N. Glickman

3:00-3:30 pm

Cytology of Gynecologic Glandular Lesions

Vanda Torous

3:30-4:00 pm

Question Period

Melinda Lerwill

4:00-4:10 pm

Break

4:10-4:20 pm

Prostate Cancer Pathology: Navigating Daily Challenges and Pitfalls

Chin-Lee Wu

4:20-5:20 pm

Challenges and Pitfalls of Pigmented Skin Lesions

Anna Stagner

5:20-6:05 pm

Question Period

Melinda Lerwill

6:05-6:15 pm

Day 5

Friday, October 30, 2026

Orthopedic Pathology

Gunnlaugur Nielsen

8:00-9:00 am

Biomarker Testing in Thoracic Diseases

Lynette Sholl

9:00-10:00 am

Break

10:00-10:15 am

Essentials of Thyroid Cytology in Everyday Practice

William Faquin

10:15-10:45 am

Leveraging Immunohistochemistry to Determine Molecular Alterations in Hematologic Malignancies

Valentina Nardi

10:45-11:15 am

Plasma Cell Neoplasms and Plasmacytoid Lymphomas

Megan Fitzpatrick

11:15 am-12:00 pm

Midday Break

12:00-12:30 pm

Slide Seminar: Head and Neck Pathology

Bayan Alzumaili

12:30-1:15 pm

Slide Seminar: Molecular Pathology

Mark Sabbagh

1:15-2:00 pm

Break

2:00-2:15 pm

Diagnosis and Workup of Amyloidosis

James Stone

2:15-3:00 pm

Distinguishing Sarcoma from Sarcomatoid Carcinoma

Ivan Chebib

3:00-3:30 pm

Current and Future Landscape for Digital Pathology and Artificial Intelligence

S. Joseph Sirintrapun

3:30-4:00 pm

Question Period

Esther Oliva

4:00-4:10 pm

Break

4:10-4:20 pm

Quality and Safety Considerations for the Practicing Surgical Pathologist

Mia DeSimone

4:20-4:50 pm

A Practical Approach to Pediatric Small Round Blue Cell Tumors

Katelyn Dannheim

4:50-5:20 pm

Intraoperative Consultation in Gynecologic Pathology

Esther Oliva

5:20-5:50 pm

Question Period

Esther Oliva

5:50-6:00 pm

Conclusion and Farewell

6:00-6:05 pm

Faculty

Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.

 

Course Directors

Bayan Alzumaili, MD

S. Emily Bachert, MD

Justine A. Barletta,  MD

John  Chambers,  BS

Ivan Chebib, MD, FRCPC

Katelyn Dannheim, MD 

Mia DeSimone, MD, MPH

Kyle Devins, MD

Michael Drage, MD, PhD

William Faquin, MD, PhD

Judith Ferry, MD

Adam Fisch, MD, PhD

Megan Fitzpatrick, MD

Ruth Foreman, MD, PhD

Jonathan N. Glickman, MD, PhD

Robert Hasserjian, MD

Mai Hoang, MD

Yin "Rex"  Hung, MD, PhD

Susan Lester, MD, PhD

Lawrence Lin, MD, PhD

Zhichun Lu, MD

Amy Ly, MD

Miranda Machacek, MD, PhD

Maria Martinez-Lage Alvarez, MD

David Meredith, MD, PHD

Mari Mino-Kenudson, MD

Jakob Moran, MD

Valentina Nardi, MD

G. Petur Nielsen, MD

Mark Sabbagh, MD, PhD

Peter Sadow, MD, PhD

Dennis Sgroi, MD

Angela Shih, MD

Lynette Sholl, MD

Stuti Shroff, MBBS, PhD

S. Joseph Sirintrapun, MD

Aliyah Sohani, MD

Anna Stagner, MD

James Stone, MD, PhD

Vanda Torous, MD

Gulisa Turashvili, MD, PhD

Charlotte Wang, MD, PhD

Chin-Lee Wu, MD, PhD

Lisa Zhang, MD

Complete Your Registration

Started a registration? Log in to enroll today.

Request Information

Interested in learning more about this program? Sign up for details.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Course Fees

Registration Details

You may register through our secure online environment and will receive an email confirmation upon receipt of your payment. Electronic syllabus and access to select recordings for 60 days after the course are included.

At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.

Review the cancellation policy.

Role Course Fee
Physician (MD/DO) $1,095
Resident/Fellow $900
Allied Health Professional / Other $1,095

Accreditation

In support of improving patient care, Harvard Medical School is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

To receive CME/CE credit, learners are required to complete the course evaluation. Once the evaluation is complete, you will be able to claim your credit and download your certificate. All evaluations and credit claims must be completed within 60 days of the course end date.

The Harvard Medical School designates this Live Virtual for a maximum of 46.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 0.50 credits of Risk Management Study. Please check your individual state licensing board requirements before claiming these credits.

For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept  AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with  AMA PRA Category 1 Credit™ for re-licensure.

The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.

The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialists (UEMS). Additional information regarding this agreement may be found on the Union of European Medical Specialists website.

The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.

Competencies

This course is designed to meet the following Institute of Medicine Core Competencies:

  • Provide Patient-Centered Care
  • Employ Evidence-Based Practice
  • Apply Quality Improvement

This course is designed to meet the following American Board of Medical Specialties (ABMS) / Accreditation Council for Graduate Medical Educational (ACGME) competencies:

  • Patient Care and Procedural Skills
  • Medical Knowledge
  • Systems-Based Practice

Disclaimer & Disclosure

CME activities accredited by Harvard Medical School are offered solely for educational purposes and do not constitute any form of certification of competency. Practitioners should always consult additional sources of information and exercise their best professional judgment before making clinical decisions of any kind.

Note: AMA PRA Category 1 Credit™ is calculated based on submission of a preliminary agenda and may be subject to change.

In accord with the disclosure policy of the Medical School as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), course planners, speakers, and content reviewers have been asked to disclose any relationships they have to companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. In addition, faculty have been asked to list any off-label uses of pharmaceuticals and/or devices for investigational or non-FDA approved purposes that they plan to discuss.

Registration for courses managed by Harvard Medical School can only be completed through Harvard Medical School’s official registration portal: cmeregistration.hms.harvard.edu. Attendee registrations made through any other sites cannot be honored and will not be refunded. Please report any unauthorized websites or solicitations for registrations.

In order to comply with applicable U.S. export control and sanctions regulations, Harvard Medical School prohibits access to and use of Harvard Medical School educational offerings, programs and resources to individuals from certain sanctioned regions or who are otherwise subject to U.S. government sanctions, unless appropriate authorization is in place.

Program Topics

Program Specialties